Skip to main content
← Back to companies
Formation Bio logo

Formation Bio

19 open9 filled
New York, New York, United StatesFounded 2013181+ employeesGrowth raisedGrowthPrivate
Last round: series d · $372M · Jun 2024(4 rounds total)
Founded by Benjamine Liu, Kit Dobyns, Linhao ZhangTech-native pharma company acquiring and developing clinical-stage assets via proprietary sourcing, evaluation, and clinical trial infrastructure
Backed by(20 investors)
Andreessen HorowitzLachy GroomSam AltmanSV AngelSanofiFPV VenturesThrive CapitalSequoia CapitalEmerson CollectiveHyphen CapitalArrowMark PartnersFelicisSpark Capital

Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop them faster in order to accelerate access to new treatments for patients, and to unlock greater value per program.

Ready to start your space career at Formation Bio?

Shipping like we're funded. We're not. No affiliation.

Sequoia logo
Y Combinator logo
Founders Fund logo
a16z logo